Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ovid Therapeutics, Inc. | 7,531,996 | 7,531,996 | 0 | 2,485 | 9,792 | 59.82% | +7,306 |
| Equillium, Inc. | 1,824,977 | 1,824,977 | 0 | 575 | 2,610 | 15.94% | +2,034 |
| Shattuck Labs, Inc. | 515,619 | 515,619 | 0 | 408 | 1,232 | 7.53% | +824 |
| Lyell Immunopharma, Inc. | 41,165 | 54,887 | +13,722 | 364 | 891 | 5.45% | +527 |
| Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 1,475,121 | 1,475,121 | 0 | 1,003 | 1,243 | 7.59% | +240 |
| Standard Biotools, Inc. | 16,515 | 16,515 | 0 | 20 | 21 | 0.13% | +2 |
| Rani Therapeutics Holdings, Inc. | 203,190 | 203,190 | 0 | 104 | 102 | 0.62% | -3 |
| Third Harmonic Bio, Inc. | 36,835 | 0 | -36,835 | 200 | 0 | — | -200 |
| American Well Corporation | 77,733 | 77,733 | 0 | 691 | 478 | 2.92% | -213 |
| Turnstone Biologics | 895,824 | 0 | -895,824 | 322 | 0 | — | -322 |
| HilleVax, Inc. | 6,724,000 | 0 | -6,724,000 | 13,381 | 0 | — | -13,381 |